Chemical Genomic Approaches to Study Model Microbes

Chemistry and Biology

Volumn 17, Issue 6, 2010, Pages 624-632

  Barker, Courtney A ^a   Farha, Maya A ^a   Brown, Eric D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

CHEMBIO; MICROBIO; SYSBIO

Indexed keywords

ANIMAL; DNA MICROARRAY; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; HUMAN; METHODOLOGY; MICROBIOLOGY; PROMOTER REGION; REVIEW; PROCEDURES;

ANIMALS; GENE DOSAGE; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MICROBIOLOGY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC;

EID: 77953715540     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2010.05.010     Document Type: Review

References (103)

1. Arnoldo A., Curak J., Kittanakom S., Chevelev I., Lee V.T., Sahebol-Amri M., Koscik B., Ljuma L., Roy P.J., Bedalov A., et al. Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen. PLoS Genet. 4 (2008) e1000005
2. Artavanis-Tsakonas K., Misaghi S., Comeaux C.A., Catic A., Spooner E., Duraisingh M.T., and Ploegh H.L. Identification by functional proteomics of a deubiquitinating/deNeddylating enzyme in Plasmodium falciparum. Mol. Microbiol. 61 (2006) 1187-1195
3. Baba T., Ara T., Hasegawa M., Takai Y., Okumura Y., Baba M., Datsenko K.A., Tomita M., Wanner B.L., and Mori H. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2 (2006) 2006-2008
4. Baetz K., McHardy L., Gable K., Tarling T., Reberioux D., Bryan J., Andersen R.J., Dunn T., Hieter P., and Roberge M. Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. Proc. Natl. Acad. Sci. USA 101 (2004) 4525-4530
5. Bansal M., Della Gatta G., and di Bernardo D. Inference of gene regulatory networks and compound mode of action from time course gene expression profiles. Bioinformatics 22 (2006) 815-822
6. Bansal M., Belcastro V., Ambesi-Impiombato A., and di Bernardo D. How to infer gene networks from expression profiles. Mol. Syst. Biol. 3 (2007) 78
7. Bantscheff M., Eberhard D., Abraham Y., Bastuck S., Boesche M., Hobson S., Mathieson T., Perrin J., Raida M., Rau C., et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat. Biotechnol. 25 (2007) 1035-1044
8. Barglow K.T., and Cravatt B.F. Activity-based protein profiling for the functional annotation of enzymes. Nat. Methods 4 (2007) 822-827
9. Barone R., Barone R., Arbelot M., and Chanon M. GASP: a computer program to generate automatically polycyclic structures. Tetrahedron 57 (2001) 6035-6042
10. Birrell G.W., Brown J.A., Wu H.I., Giaever G., Chu A.M., Davis R.W., and Brown J.M. Transcriptional response of Saccharomyces cerevisiae to DNA-damaging agents does not identify the genes that protect against these agents. Proc. Natl. Acad. Sci. USA 99 (2002) 8778-8783
11. Bollenbach T., Quan S., Chait R., and Kishony R. Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139 (2009) 707-718
12. Bottcher T., and Sieber S.A. Beta-lactones as privileged structures for the active-site labeling of versatile bacterial enzyme classes. Angew. Chem. Int. Ed. Engl. 47 (2008) 4600-4603
13. Bottcher T., and Sieber S.A. Beta-lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus. J. Am. Chem. Soc. 130 (2008) 14400-14401
14. Bottcher T., and Sieber S.A. Structurally refined beta-lactones as potent inhibitors of devastating bacterial virulence factors. ChemBioChem 10 (2009) 663-666
15. Bradner J.E., McPherson O.M., Mazitschek R., Barnes-Seeman D., Shen J.P., Dhaliwal J., Stevenson K.E., Duffner J.L., Park S.B., Neuberg D.S., et al. A robust small-molecule microarray platform for screening cell lysates. Chem. Biol. 13 (2006) 493-504
16. Brandner C.J., Maier R.H., Henderson D.S., Hintner H., Bauer J.W., and Onder K. The ORFeome of Staphylococcus aureus v 1.1. BMC. Genomics 9 (2008) 321
17. Breidenstein E.B., Khaira B.K., Wiegand I., Overhage J., and Hancock R.E. Complex ciprofloxacin resistome revealed by screening a Pseudomonas aeruginosa mutant library for altered susceptibility. Antimicrob. Agents Chemother. 52 (2008) 4486-4491
18. Brettin T., Altherr M.R., Du Y., Mason R.M., Friedrich A., Potter L., Langford C., Keller T.J., Jens J., Howie H., et al. Expression capable library for studies of Neisseria gonorrhoeae, version 1.0. BMC Microbiol. 5 (2005) 50
19. Burdine L., and Kodadek T. Target identification in chemical genetics: the (often) missing link. Chem. Biol. 11 (2004) 593-597
20. Butcher R.A., Bhullar B.S., Perlstein E.O., Marsischky G., LaBaer J., and Schreiber S.L. Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway. Nat. Chem. Biol. 2 (2006) 103-109
21. Butland G., Peregrin-Alvarez J.M., Li J., Yang W., Yang X., Canadien V., Starostine A., Richards D., Beattie B., Krogan N., et al. Interaction network containing conserved and essential protein complexes in Escherichia coli. Nature 433 (2005) 531-537
22. Butland G., Babu M., Diaz-Mejia J.J., Bohdana F., Phanse S., Gold B., Yang W., Li J., Gagarinova A.G., Pogoutse O., et al. eSGA: E. coli synthetic genetic array analysis. Nat. Methods 5 (2008) 789-795
23. Chalker A.F., and Lunsford R.D. Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach. Pharmacol. Ther. 95 (2002) 1-20
24. Costanzo M., Baryshnikova A., Bellay J., Kim Y., Spear E.D., Sevier C.S., Ding H., Koh J.L., Toufighi K., Mostafavi S., et al. The genetic landscape of a cell. Science 327 (2010) 425-431
25. Cravatt B.F., Wright A.T., and Kozarich J.W. Activity-based protein profiling: from enzyme chemistry to proteomic chemistry. Annu. Rev. Biochem. 77 (2008) 383-414
26. Dalhoff C., Huben M., Lenz T., Poot P., Nordhoff E., Koster H., and Weinhold E. Synthesis of S-adenosyl-L-homocysteine capture compounds for selective photoinduced isolation of methyltransferases. ChemBioChem 11 (2009) 256-265
27. Davies J., Spiegelman G.B., and Yim G. The world of subinhibitory antibiotic concentrations. Curr. Opin. Microbiol. 9 (2006) 445-453
28. di Bernardo D., Thompson M.J., Gardner T.S., Chobot S.E., Eastwood E.L., Wojtovich A.P., Elliott S.J., Schaus S.E., and Collins J.J. Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. Nat. Biotechnol. 23 (2005) 377-383
29. Donald R.G., Skwish S., Forsyth R.A., Anderson J.W., Zhong T., Burns C., Lee S., Meng X., LoCastro L., Jarantow L.W., et al. A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds. Chem. Biol. 16 (2009) 826-836
30. Duffner J.L., Clemons P.A., and Koehler A.N. A pipeline for ligand discovery using small-molecule microarrays. Curr. Opin. Chem. Biol. 11 (2007) 74-82
31. Duo M., Hou S., and Ren D. Identifying Escherichia coli genes involved in intrinsic multidrug resistance. Appl. Microbiol. Biotechnol. 81 (2008) 731-741
32. Eckert H., and Bajorath J. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. Drug Discov. Today 12 (2007) 225-233
33. Faith J.J., Hayete B., Thaden J.T., Mogno I., Wierzbowski J., Cottarel G., Kasif S., Collins J.J., and Gardner T.S. Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles. PLoS Biol. 5 (2007) e8
34. Faith J.J., Driscoll M.E., Fusaro V.A., Cosgrove E.J., Hayete B., Juhn F.S., Schneider S.J., and Gardner T.S. Many Microbe Microarrays Database: uniformly normalized Affymetrix compendia with structured experimental metadata. Nucleic Acids Res. 36 (2008) D866-D870
35. Fischer H.P., Brunner N.A., Wieland B., Paquette J., Macko L., Ziegelbauer K., and Freiberg C. Identification of antibiotic stress-inducible promoters: a systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery. Genome Res. 14 (2004) 90-98
36. Freiberg C., Fischer H.P., and Brunner N.A. Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants. Antimicrob. Agents Chemother. 49 (2005) 749-759
37. Gardner T.S., di Bernardo D., Lorenz D., and Collins J.J. Inferring genetic networks and identifying compound mode of action via expression profiling. Science 301 (2003) 102-105
38. Gelperin D.M., White M.A., Wilkinson M.L., Kon Y., Kung L.A., Wise K.J., Lopez-Hoyo N., Jiang L., Piccirillo S., Yu H., et al. Biochemical and genetic analysis of the yeast proteome with a movable ORF collection. Genes Dev. 19 (2005) 2816-2826
39. Giaever G., Shoemaker D.D., Jones T.W., Liang H., Winzeler E.A., Astromoff A., and Davis R.W. Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat. Genet. 21 (1999) 278-283
40. Giaever G., Chu A.M., Ni L., Connelly C., Riles L., Veronneau S., Dow S., Lucau-Danila A., Anderson K., Andre B., et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 418 (2002) 387-391
41. Giaever G., Flaherty P., Kumm J., Proctor M., Nislow C., Jaramillo D.F., Chu A.M., Jordan M.I., Arkin A.P., and Davis R.W. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. USA 101 (2004) 793-798
42. Goh E.B., Yim G., Tsui W., McClure J., Surette M.G., and Davies J. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc. Natl. Acad. Sci. USA 99 (2002) 17025-17030
43. Greenbaum D.C., Baruch A., Grainger M., Bozdech Z., Medzihradszky K.F., Engel J., DeRisi J., Holder A.A., and Bogyo M. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science 298 (2002) 2002-2006
44. Hallen K., Bjorkegren J., and Tegner J. Detection of compound mode of action by computational integration of whole-genome measurements and genetic perturbations. BMC Bioinformatics 7 (2006) 51
45. Hang H.C., Loureiro J., Spooner E., van der Velden A.W., Kim Y.M., Pollington A.M., Maehr R., Starnbach M.N., and Ploegh H.L. Mechanism-based probe for the analysis of cathepsin cysteine proteases in living cells. ACS Chem. Biol. 1 (2006) 713-723
46. Hansen S., Lewis K., and Vulic M. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob. Agents Chemother. 52 (2008) 2718-2726
47. Hekmat O., Kim Y.W., Williams S.J., He S., and Withers S.G. Active-site peptide "fingerprinting" of glycosidases in complex mixtures by mass spectrometry. Discovery of a novel retaining beta-1,4-glycanase in Cellulomonas fimi. J. Biol. Chem. 280 (2005) 35126-35135
48. Hillenmeyer M.E., Fung E., Wildenhain J., Pierce S.E., Hoon S., Lee W., Proctor M., St Onge R.P., Tyers M., Koller D., et al. The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320 (2008) 362-365
49. Hoon S., Smith A.M., Wallace I.M., Suresh S., Miranda M., Fung E., Proctor M., Shokat K.M., Zhang C., Davis R.W., et al. An integrated platform of genomic assays reveals small-molecule bioactivities. Nat. Chem. Biol. 4 (2008) 498-506
50. Hoon S., St Onge R.P., Giaever G., and Nislow C. Yeast chemical genomics and drug discovery: an update. Trends Pharmacol. Sci. 29 (2008) 499-504
51. Huber J., Donald R.G., Lee S.H., Jarantow L.W., Salvatore M.J., Meng X., Painter R., Onishi R.H., Occi J., Dorso K., et al. Chemical genetic identification of peptidoglycan inhibitors potentiating carbapenem activity against methicillin-resistant Staphylococcus aureus. Chem. Biol. 16 (2009) 837-848
52. Hughes T.R., Marton M.J., Jones A.R., Roberts C.J., Stoughton R., Armour C.D., Bennett H.A., Coffey E., Dai H., He Y.D., et al. Functional discovery via a compendium of expression profiles. Cell 102 (2000) 109-126
53. Jacobs M.A., Alwood A., Thaipisuttikul I., Spencer D., Haugen E., Ernst S., Will O., Kaul R., Raymond C., Levy R., et al. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 100 (2003) 14339-14344
54. Jeffery D.A., and Bogyo M. Chemical proteomics and its application to drug discovery. Curr. Opin. Biotechnol. 14 (2003) 87-95
55. Jeong H., Mason S.P., Barabasi A.L., and Oltvai Z.N. Lethality and centrality in protein networks. Nature 411 (2001) 41-42
56. Jiang B., Xu D., Allocco J., Parish C., Davison J., Veillette K., Sillaots S., Hu W., Rodriguez-Suarez R., Trosok S., et al. PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products. Chem. Biol. 15 (2008) 363-374
57. Kaldalu N., Mei R., and Lewis K. Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile. Antimicrob. Agents Chemother. 48 (2004) 890-896
58. Kemmer D., McHardy L.M., Hoon S., Reberioux D., Giaever G., Nislow C., Roskelley C.D., and Roberge M. Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis. BMC Microbiol. 9 (2009) 9
59. Kitagawa M., Ara T., Arifuzzaman M., Ioka-Nakamichi T., Inamoto E., Toyonaga H., and Mori H. DNA Res. Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research 12 (2005) 291-299
60. Klebe G. Recent developments in structure-based drug design. J. Mol. Med. 78 (2000) 269-281
61. Kobayashi K., Ehrlich S.D., Albertini A., Amati G., Andersen K.K., Arnaud M., Asai K., Ashikaga S., Aymerich S., Bessieres P., et al. Essential Bacillus subtilis genes. Proc. Natl. Acad. Sci. USA 100 (2003) 4678-4683
62. Kohanski M.A., Dwyer D.J., Hayete B., Lawrence C.A., and Collins J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130 (2007) 797-810
63. Kohanski M.A., Dwyer D.J., Wierzbowski J., Cottarel G., and Collins J.J. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135 (2008) 679-690
64. Kung C., Kenski D.M., Dickerson S.H., Howson R.W., Kuyper L.F., Madhani H.D., and Shokat K.M. Chemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor. Proc. Natl. Acad. Sci. USA 102 (2005) 3587-3592
65. Labaer J., Qiu Q., Anumanthan A., Mar W., Zuo D., Murthy T.V., Taycher H., Halleck A., Hainsworth E., Lory S., et al. The Pseudomonas aeruginosa PA01 gene collection. Genome Res. 14 (2004) 2190-2200
66. Lee W., St Onge R.P., Proctor M., Flaherty P., Jordan M.I., Arkin A.P., Davis R.W., Nislow C., and Giaever G. Genome-wide requirements for resistance to functionally distinct DNA-damaging agents. PLoS Genet. 1 (2005) e24
67. Leung D., Hardouin C., Boger D.L., and Cravatt B.F. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat. Biotechnol. 21 (2003) 687-691
68. Li X., Zolli-Juran M., Cechetto J.D., Daigle D.M., Wright G.D., and Brown E.D. Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. Chem. Biol. 11 (2004) 1423-1430
69. Liberati N.T., Urbach J.M., Miyata S., Lee D.G., Drenkard E., Wu G., Villanueva J., Wei T., and Ausubel F.M. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc. Natl. Acad. Sci. USA 103 (2006) 2833-2838
70. Luesch H., Wu T.Y., Ren P., Gray N.S., Schultz P.G., and Supek F. A genome-wide overexpression screen in yeast for small-molecule target identification. Chem. Biol. 12 (2005) 55-63
71. Lum P.Y., Armour C.D., Stepaniants S.B., Cavet G., Wolf M.K., Butler J.S., Hinshaw J.C., Garnier P., Prestwich G.D., Leonardson A., et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 116 (2004) 121-137
72. MacBeath G., and Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science 289 (2000) 1760-1763
73. Marton M.J., DeRisi J.L., Bennett H.A., Iyer V.R., Meyer M.R., Roberts C.J., Stoughton R., Burchard J., Slade D., Dai H., et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med. 4 (1998) 1293-1301
74. Mendez-Ortiz M.M., Hyodo M., Hayakawa Y., and Membrillo-Hernandez J. Genome-wide transcriptional profile of Escherichia coli in response to high levels of the second messenger 3′,5′-cyclic diguanylic acid. J. Biol. Chem. 281 (2006) 8090-8099
75. Misaghi S., Balsara Z.R., Catic A., Spooner E., Ploegh H.L., and Starnbach M.N. Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol. Microbiol. 61 (2006) 142-150
76. Mori H., Yamamoto N., Dose H., Nakahigashi K., Datsenko K., and Wanner B. Resources for Escherichia coli Systems Biology (2009), Springer Science, Dordrecht, Netherlands
77. Parsons A.B., Brost R.L., Ding H., Li Z., Zhang C., Sheikh B., Brown G.W., Kane P.M., Hughes T.R., and Boone C. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 22 (2004) 62-69
78. Parsons A.B., Lopez A., Givoni I.E., Williams D.E., Gray C.A., Porter J., Chua G., Sopko R., Brost R.L., Ho C.H., et al. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126 (2006) 611-625
79. Pathania R., Zlitni S., Barker C., Das R., Gerritsma D.A., Lebert J., Awuah E., Melacini G., Capretta F.A., and Brown E.D. Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting. Nat. Chem. Biol. 5 (2009) 849-856
80. Piggott A.M., and Karuso P. Quality, not quantity: the role of natural products and chemical proteomics in modern drug discovery. Comb. Chem. High Throughput Screen. 7 (2004) 607-630
81. Prelich G. Suppression mechanisms: themes from variations. Trends Genet. 15 (1999) 261-266
82. Puri A.W., and Bogyo M. Using small molecules to dissect mechanisms of microbial pathogenesis. ACS Chem. Biol. 4 (2009) 603-616
83. Rix U., Hantschel O., Durnberger G., Remsing Rix L.L., Planyavsky M., Fernbach N.V., Kaupe I., Bennett K.L., Valent P., Colinge J., et al. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood 110 (2007) 4055-4063
84. Rix U., and Superti-Furga G. Target profiling of small molecules by chemical proteomics. Nat. Chem. Biol. 5 (2009) 616-624
85. Ruiz N. Bioinformatics identification of MurJ (MviN) as the peptidoglycan lipid II flippase in Escherichia coli. Proc. Natl. Acad. Sci. USA 105 (2008) 15553-15557
86. Salama N.R., Shepherd B., and Falkow S. Global transposon mutagenesis and essential gene analysis of Helicobacter pylori. J. Bacteriol. 186 (2004) 7926-7935
87. Shaw K.J., and Morrow B.J. Transcriptional profiling and drug discovery. Curr. Opin. Pharmacol. 3 (2003) 508-512
88. Shen Y., Liu J., Estiu G., Isin B., Ahn Y.Y., Lee D.S., Barabasi A.L., Kapatral V., Wiest O., and Oltvai Z.N. Blueprint for antimicrobial hit discovery targeting metabolic networks. Proc. Natl. Acad. Sci. USA 107 (2010) 1082-1087
89. Shoemaker D.D., Lashkari D.A., Morris D., Mittmann M., and Davis R.W. Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nat. Genet. 14 (1996) 450-456
90. Specht K.M., and Shokat K.M. The emerging power of chemical genetics. Curr. Opin. Cell Biol. 14 (2002) 155-159
91. Staub I., and Sieber S.A. Beta-lactams as selective chemical probes for the in vivo labeling of bacterial enzymes involved in cell wall biosynthesis, antibiotic resistance, and virulence. J. Am. Chem. Soc. 130 (2008) 13400-13409
92. Staub I., and Sieber S.A. Beta-lactam probes as selective chemical-proteomic tools for the identification and functional characterization of resistance associated enzymes in MRSA. J. Am. Chem. Soc. 131 (2009) 6271-6276
93. Tamae C., Liu A., Kim K., Sitz D., Hong J., Becket E., Bui A., Solaimani P., Tran K.P., Yang H., et al. Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli. J. Bacteriol. 190 (2008) 5981-5988
94. Typas A., Nichols R.J., Siegele D.A., Shales M., Collins S.R., Lim B., Braberg H., Yamamoto N., Takeuchi R., Wanner B.L., et al. High-throughput, quantitative analyses of genetic interactions in E. coli. Nat. Methods 5 (2008) 781-787
95. Utaida S., Dunman P.M., Macapagal D., Murphy E., Projan S.J., Singh V.K., Jayaswal R.K., and Wilkinson B.J. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 149 (2003) 2719-2732
96. Verhelst S.H., and Bogyo M. Chemical proteomics applied to target identification and drug discovery. Biotechniques 38 (2005) 175-177
97. Winzeler E.A., Shoemaker D.D., Astromoff A., Liang H., Anderson K., Andre B., Bangham R., Benito R., Boeke J.D., Bussey H., et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285 (1999) 901-906
98. Wu H.I., Brown J.A., Dorie M.J., Lazzeroni L., and Brown J.M. Genome-wide identification of genes conferring resistance to the anticancer agents cisplatin, oxaliplatin, and mitomycin C. Cancer Res. 64 (2004) 3940-3948
99. Xu D., Jiang B., Ketela T., Lemieux S., Veillette K., Martel N., Davison J., Sillaots S., Trosok S., Bachewich C., et al. Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans. PLoS Pathog. 3 (2007) e92
100. Yan Z., Berbenetz N.M., Giaever G., and Nislow C. Precise gene-dose alleles for chemical genetics. Genetics 182 (2009) 623-626
101. Yim G., de la Cruz F., Spiegelman G.B., and Davies J. Transcription modulation of Salmonella enterica serovar Typhimurium promoters by sub-MIC levels of rifampin. J. Bacteriol. 188 (2006) 7988-7991
102. Yu L., Lopez A., Anaflous A., El Bali B., Hamal A., Ericson E., Heisler L.E., McQuibban A., Giaever G., Nislow C., et al. Chemical-genetic profiling of imidazo[1,2-a]pyridines and -pyrimidines reveals target pathways conserved between yeast and human cells. PLoS Genet. 4 (2008) e1000284
103. Zaslaver A., Bren A., Ronen M., Itzkovitz S., Kikoin I., Shavit S., Liebermeister W., Surette M.G., and Alon U. A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat. Methods 3 (2006) 623-628